368
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Reversion From Mild Cognitive Impairment To Normal Cognition: False-Positive Error Or True Restoration Thanks To Cognitive Control Ability?

, ORCID Icon, ORCID Icon, , , ORCID Icon & show all
Pages 3021-3032 | Published online: 25 Oct 2019

References

  • Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–308. doi:10.1001/archneur.56.3.30310190820
  • Lopez OL, Becker JT, Chang YF, et al. Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study-Cognition Study. Neurology. 2012;79(15):1599–1606. doi:10.1212/WNL.0b013e31826e25f023019262
  • Pandya SY, Lacritz LH, Weiner MF, Deschner M, Woon FL. Predictors of reversion from mild cognitive impairment to normal cognition. Dement Geriatr Cogn Disord. 2017;43(3–4):204–214. doi:10.1159/00045607028301848
  • Roberts RO, Knopman DS, Mielke MM, et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology. 2014;82(4):317–325. doi:10.1212/WNL.000000000000005524353333
  • Tokuchi R, Hishikawa N, Kurata T, et al. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer’s disease and reverting to normal cognition. J Neurol Sci. 2014;346(1–2):288–292. doi:10.1016/j.jns.2014.09.01225248955
  • Sachdev PS, Lipnicki DM, Crawford J, et al. Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study. PLoS One. 2013;8(3):e59649. doi:10.1371/journal.pone.005964923544083
  • Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Neurology. 2012;79(15):1591–1598. doi:10.1212/WNL.0b013e31826e26b723019264
  • Lopez OL, Jagust WJ, Dulberg C, et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol. 2003;60(10):1394–1399. doi:10.1001/archneur.60.10.139414568809
  • Ravaglia G, Forti P, Montesi F, et al. Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population. J Am Geriatr Soc. 2008;56(1):51–58. doi:10.1111/j.1532-5415.2007.01503.x18028343
  • Clark LR, Delano-Wood L, Libon DJ, et al. Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes? J Int Neuropsychol Soc. 2013;19(6):635–645. doi:10.1017/S135561771300031323552486
  • Nettiksimmons J, DeCarli C, Landau S, Beckett L. Alzheimer’s disease neuroimaging I. Biological heterogeneity in ADNI amnestic mild cognitive impairment. Alzheimers Dement. 2014;10(5):511–521 e511. doi:10.1016/j.jalz.2013.09.00324418061
  • Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41(7):1006–1009. doi:10.1212/wnl.41.7.10062067629
  • Larrieu S, Letenneur L, Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59(10):1594–1599. doi:10.1212/01.wnl.0000034176.07159.f812451203
  • Brooks BL, Iverson GL, White T. Substantial risk of “Accidental MCI” in healthy older adults: base rates of low memory scores in neuropsychological assessment. J Int Neuropsychol Soc. 2007;13(3):490–500. doi:10.1017/S135561770707053117445298
  • de Rotrou J, Wenisch E, Chausson C, Dray F, Faucounau V, Rigaud AS. Accidental MCI in healthy subjects: a prospective longitudinal study. Eur J Neurol. 2005;12(11):879–885. doi:10.1111/j.1468-1331.2005.01100.x16241977
  • Gao Q, Gwee X, Feng L, et al. Mild cognitive impairment reversion and progression: rates and predictors in community-living older persons in the singapore longitudinal ageing studies cohort. Dement Geriatr Cogn Dis Extra. 2018;8(2):226–237. doi:10.1159/00048893630022996
  • Aretouli E, Tsilidis KK, Brandt J. Four-year outcome of mild cognitive impairment: the contribution of executive dysfunction. Neuropsychology. 2013;27(1):95–106. doi:10.1037/a003048123106114
  • Brooks BL, Iverson GL, Holdnack JA, Feldman HH. Potential for misclassification of mild cognitive impairment: a study of memory scores on the Wechsler Memory Scale-III in healthy older adults. J Int Neuropsychol Soc. 2008;14(3):463–478. doi:10.1017/S135561770808052118419845
  • Edmonds EC, Delano-Wood L, Clark LR, et al. Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement. 2015;11(4):415–424. doi:10.1016/j.jalz.2014.03.00524857234
  • Oltra-Cucarella J, Sanchez-Sansegundo M, Lipnicki DM, et al. Using base rate of low scores to identify progression from amnestic mild cognitive impairment to Alzheimer’s disease. J Am Geriatr Soc. 2018;66(7):1360–1366. doi:10.1111/jgs.1541229745971
  • Sugarman MA, Alosco ML, Tripodis Y, Steinberg EG, Stern RA. Neuropsychiatric symptoms and the diagnostic stability of mild cognitive impairment. J Alzheimers Dis. 2018;62(4):1841–1855. doi:10.3233/JAD-17052729614641
  • Teng E, Tingus KD, Lu PH, Cummings JL. Persistence of neuropsychological testing deficits in mild cognitive impairment. Dement Geriatr Cogn Disord. 2009;28(2):168–178. doi:10.1159/00023573219707017
  • Cooper DB, Lacritz LH, Weiner MF, Rosenberg RN, Cullum CM. Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions. Alzheimer Dis Assoc Disord. 2004;18(3):120–122.15494616
  • Duff K, Beglinger LJ, Van Der Heiden S, et al. Short-term practice effects in amnestic mild cognitive impairment: implications for diagnosis and treatment. Int Psychogeriatr. 2008;20(5):986–999. doi:10.1017/S104161020800725418405398
  • Duff K, Lyketsos CG, Beglinger LJ, et al. Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatr Psychiatry. 2011;19(11):932–939. doi:10.1097/JGP.0b013e318209dd3a22024617
  • Dodge HH, Wang CN, Chang CC, Ganguli M. Terminal decline and practice effects in older adults without dementia: the MoVIES project. Neurology. 2011;77(8):722–730. doi:10.1212/WNL.0b013e31822b006821832224
  • Duff K, Beglinger LJ, Moser DJ, Paulsen JS, Schultz SK, Arndt S. Predicting cognitive change in older adults: the relative contribution of practice effects. Arch Clin Neuropsychol. 2010;25(2):81–88. doi:10.1093/arclin/acp10520064816
  • Seo EH, Kim H, Choi KY, Lee KH, Choo IH. Pre-mild cognitive impairment: can visual memory predict who rapidly convert to mild cognitive impairment? Psychiatry Investig. 2018;15(9):869–875. doi:10.30773/pi.2018.07.29.1
  • Seo EH, Kim H, Lee KH, Choo IH. Altered executive function in pre-mild cognitive impairment. J Alzheimers Dis. 2016;54(3):933–940. doi:10.3233/JAD-16005227567814
  • Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240–246. doi:10.1111/j.1365-2796.2004.01380.x15324367
  • Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–356. doi:10.2214/ajr.149.2.3513496763
  • Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–572. doi:10.1192/bjp.140.6.5667104545
  • Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–2414. doi:10.1212/wnl.43.11.2412-a
  • Kang SJ, Choi SH, Lee BH, Kwon JC, Na DL, Han SH. Validity and reliability of Korean-Instrumental activities of daily living. Korean J Neurosci. 2002;20:8–14.
  • Organization WH. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Geneva: World Health Organization Western Pacific Regional Office; 2000.
  • Yang DW, Cho BL, Chey JY, Kim SY, Kim BS. The development and validation of Korean Dementia Screening Questionnaire (KDSQ). J Korean Neurol Assoc. 2002;20(2):135–141.
  • Youn JC, Kim KW, Lee DY, et al. Development of the Subjective memory complaints questionnaire. Dement Geriatr Cogn Disord. 2009;27(4):310–317. doi:10.1159/00020551219252402
  • Kim JY, Park JH, Lee JJ, et al. Standardization of the korean version of the geriatric depression scale: reliability, validity, and factor structure. Psychiatry Investig. 2008;5(4):232–238. doi:10.4306/pi.2008.5.4.232
  • Kang Y, Jang S, Na DL. Seoul Neuropsychological Screenign Battery (SNSB) 2nd ed. Seoul: Human Brain Research & Consulting Co; 2012.
  • Nijenhuis JT, Choi KY, Choi YY, et al. Differences between APOE carriers and non-APOE carriers on neurocognitive tests: Jensen effects? Am J Alzheimers Dis Other Demen. 2018;33(6):353–361. doi:10.1177/153331751876589529607654
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association Press; 1994.
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology. 1984;34(7):939–944. doi:10.1212/wnl.34.7.9396610841
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289–300. doi:10.1111/rssb.1995.57.issue-1
  • Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol. 2008;63(4):494–506. doi:10.1002/ana.2132618300306
  • Malek-Ahmadi M. Reversion from mild cognitive impairment to normal cognition: a meta-analysis. Alzheimer Dis Assoc Disord. 2016;30(4):324–330. doi:10.1097/WAD.000000000000014526908276
  • Petersen RC. Does the source of subjects matter?: absolutely! Neurology. 2010;74(22):1754–1755. doi:10.1212/WNL.0b013e3181e533e720484685
  • Roh HW, Hong CH, Lee Y, et al. Clinical conversion or reversion of mild cognitive impairment in community versus hospital based studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea). J Alzheimers Dis. 2016;53(2):463–473. doi:10.3233/JAD-16034127163831
  • Johnson DK, Storandt M, Morris JC, Galvin JE. Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch Neurol. 2009;66(10):1254–1259. doi:10.1001/archneurol.2009.15819822781
  • Watanabe K, Ogino T, Nakano K, et al. The Rey-Osterrieth complex figure as a measure of executive function in childhood. Brain Dev. 2005;27(8):564–569. doi:10.1016/j.braindev.2005.02.00716310591
  • Diamond A. Executive functions. Annu Rev Psychol. 2013;64:135–168. doi:10.1146/annurev-psych-113011-14375023020641
  • Badre D. Cognitive control, hierarchy, and the rostro-caudal organization of the frontal lobes. Trends Cogn Sci. 2008;12(5):193–200. doi:10.1016/j.tics.2008.02.00418403252
  • Mackie MA, Van Dam NT, Fan J. Cognitive control and attentional functions. Brain Cogn. 2013;82(3):301–312. doi:10.1016/j.bandc.2013.05.00423792472
  • Nigg JT. Annual research review: on the relations among self-regulation, self-control, executive functioning, effortful control, cognitive control, impulsivity, risk-taking, and inhibition for developmental psychopathology. J Child Psychol Psychiatry. 2017;58(4):361–383. doi:10.1111/jcpp.1267528035675
  • Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci. 2001;24:167–202. doi:10.1146/annurev.neuro.24.1.16711283309
  • Henry JD, Crawford JR. A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology. 2004;18(2):284–295. doi:10.1037/0894-4105.18.2.28415099151
  • Meinzer M, Flaisch T, Wilser L, et al. Neural signatures of semantic and phonemic fluency in young and old adults. J Cogn Neurosci. 2009;21(10):2007–2018. doi:10.1162/jocn.2009.2121919296728
  • Varjacic A, Mantini D, Demeyere N, Gillebert CR. Neural signatures of Trail Making Test performance: evidence from lesion-mapping and neuroimaging studies. Neuropsychologia. 2018;115:78–87. doi:10.1016/j.neuropsychologia.2018.03.03129596856
  • Kaduszkiewicz H, Eisele M, Wiese B, et al. Prognosis of mild cognitive impairment in general practice: results of the German AgeCoDe study. Ann Fam Med. 2014;12(2):158–165. doi:10.1370/afm.159624615312
  • Aisen PS, Petersen RC, Donohue M, Weiner MW. Alzheimer’s disease neuroimaging I. Alzheimer’s disease neuroimaging initiative 2 clinical core: progress and plans. Alzheimers Dement. 2015;11(7):734–739. doi:10.1016/j.jalz.2015.05.00526194309
  • Park MH, Han C. Is there an MCI reversion to cognitively normal? Analysis of Alzheimer’s disease biomarkers profiles. Int Psychogeriatr. 2015;27(3):429–437. doi:10.1017/S104161021400212925255915
  • Palmer BW, Boone KB, Lesser IM, Wohl MA. Base rates of “impaired” neuropsychological test performance among healthy older adults. Arch Clin Neuropsychol. 1998;13(6):503–511.14590634
  • Salthouse TA. Frequent assessments may obscure cognitive decline. Psychol Assess. 2014;26(4):1063–1069. doi:10.1037/pas000000724840179
  • Machulda MM, Pankratz VS, Christianson TJ, et al. Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging. Clin Neuropsychol. 2013;27(8):1247–1264. doi:10.1080/13854046.2013.83656724041121